nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—CHRM1—Amine ligand-binding receptors—ADRB1—periodontitis	0.0164	0.0164	CbGpPWpGaD
Escitalopram—ADRA1A—Amine ligand-binding receptors—ADRB1—periodontitis	0.0161	0.0161	CbGpPWpGaD
Escitalopram—CYP2C19—Melatonin metabolism and effects—ADRB1—periodontitis	0.014	0.014	CbGpPWpGaD
Escitalopram—CYP2D6—Melatonin metabolism and effects—ADRB1—periodontitis	0.0129	0.0129	CbGpPWpGaD
Escitalopram—SLC6A4—Monoamine Transport—IL1B—periodontitis	0.0125	0.0125	CbGpPWpGaD
Escitalopram—SLC6A2—Monoamine Transport—IL1B—periodontitis	0.0108	0.0108	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—IL13—periodontitis	0.0107	0.0107	CbGpPWpGaD
Escitalopram—CYP3A4—Aflatoxin activation and detoxification—GGT1—periodontitis	0.0102	0.0102	CbGpPWpGaD
Escitalopram—SLC6A3—Monoamine Transport—IL1B—periodontitis	0.00953	0.00953	CbGpPWpGaD
Escitalopram—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—periodontitis	0.00949	0.00949	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—IL1RN—periodontitis	0.00938	0.00938	CbGpPWpGaD
Escitalopram—HRH1—IL-4 Signaling Pathway—IL4—periodontitis	0.00917	0.00917	CbGpPWpGaD
Escitalopram—SLC6A4—Monoamine Transport—TNF—periodontitis	0.00908	0.00908	CbGpPWpGaD
Escitalopram—SLC6A4—NRF2 pathway—GGT1—periodontitis	0.00858	0.00858	CbGpPWpGaD
Escitalopram—CYP2C19—Arachidonic acid metabolism—GGT1—periodontitis	0.00784	0.00784	CbGpPWpGaD
Escitalopram—SLC6A2—Monoamine Transport—TNF—periodontitis	0.00781	0.00781	CbGpPWpGaD
Escitalopram—SLC6A3—Dopaminergic Neurogenesis—TGFB1—periodontitis	0.0078	0.0078	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00747	0.00747	CbGpPWpGaD
Escitalopram—SLC6A2—NRF2 pathway—GGT1—periodontitis	0.00738	0.00738	CbGpPWpGaD
Escitalopram—SLC6A3—Monoamine Transport—TNF—periodontitis	0.00692	0.00692	CbGpPWpGaD
Escitalopram—SLC6A4—NRF2 pathway—AGER—periodontitis	0.00683	0.00683	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—IL1A—periodontitis	0.00676	0.00676	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—IL10—periodontitis	0.00672	0.00672	CbGpPWpGaD
Escitalopram—SLC6A3—NRF2 pathway—GGT1—periodontitis	0.00654	0.00654	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00647	0.00647	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00645	0.00645	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL3—periodontitis	0.00635	0.00635	CbGpPWpGaD
Escitalopram—SLC6A4—Circadian rythm related genes—NTRK1—periodontitis	0.00627	0.00627	CbGpPWpGaD
Escitalopram—SLC6A2—NRF2 pathway—AGER—periodontitis	0.00587	0.00587	CbGpPWpGaD
Escitalopram—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.00583	0.00583	CbGpPWpGaD
Escitalopram—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB1—periodontitis	0.00574	0.00574	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—CXCL3—periodontitis	0.00569	0.00569	CbGpPWpGaD
Escitalopram—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00562	0.00562	CbGpPWpGaD
Escitalopram—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—periodontitis	0.00545	0.00545	CbGpPWpGaD
Escitalopram—SLC6A3—NRF2 pathway—AGER—periodontitis	0.0052	0.0052	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—CXCL3—periodontitis	0.00493	0.00493	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—CXCL3—periodontitis	0.00491	0.00491	CbGpPWpGaD
Escitalopram—CHRM1—Regulation of Actin Cytoskeleton—CD14—periodontitis	0.00491	0.00491	CbGpPWpGaD
Escitalopram—HRH1—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00487	0.00487	CbGpPWpGaD
Escitalopram—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00485	0.00485	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—CXCL3—periodontitis	0.00484	0.00484	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00481	0.00481	CbGpPWpGaD
Escitalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—CXCR2—periodontitis	0.00478	0.00478	CbGpPWpGaD
Escitalopram—SLC6A4—Circadian rythm related genes—PPARA—periodontitis	0.00475	0.00475	CbGpPWpGaD
Escitalopram—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—periodontitis	0.0046	0.0046	CbGpPWpGaD
Escitalopram—HTR2C—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00437	0.00437	CbGpPWpGaD
Escitalopram—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00435	0.00435	CbGpPWpGaD
Escitalopram—SLC6A4—Circadian rythm related genes—NOS2—periodontitis	0.0042	0.0042	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00417	0.00417	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00416	0.00416	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR2—periodontitis	0.00409	0.00409	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00383	0.00383	CbGpPWpGaD
Escitalopram—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00379	0.00379	CbGpPWpGaD
Escitalopram—CHRM1—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00377	0.00377	CbGpPWpGaD
Escitalopram—HRH1—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00377	0.00377	CbGpPWpGaD
Escitalopram—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.00376	0.00376	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—NTRK1—periodontitis	0.00376	0.00376	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00374	0.00374	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00373	0.00373	CbGpPWpGaD
Escitalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR2—periodontitis	0.00371	0.00371	CbGpPWpGaD
Escitalopram—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB1—periodontitis	0.0037	0.0037	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—CXCL8—periodontitis	0.00367	0.00367	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—CXCR2—periodontitis	0.00367	0.00367	CbGpPWpGaD
Escitalopram—CYP2C19—Arachidonic acid metabolism—PTGS2—periodontitis	0.00365	0.00365	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—IL1B—periodontitis	0.00352	0.00352	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00332	0.00332	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00331	0.00331	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—periodontitis	0.00326	0.00326	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00324	0.00324	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00323	0.00323	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00323	0.00323	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00322	0.00322	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CXCL3—periodontitis	0.00321	0.00321	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR2—periodontitis	0.00318	0.00318	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—CXCR2—periodontitis	0.00318	0.00318	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—periodontitis	0.00317	0.00317	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—CXCR2—periodontitis	0.00317	0.00317	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—CXCR2—periodontitis	0.00312	0.00312	CbGpPWpGaD
Escitalopram—CYP2C19—Biological oxidations—GGT1—periodontitis	0.00292	0.00292	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CXCL3—periodontitis	0.00292	0.00292	CbGpPWpGaD
Escitalopram—SLC6A4—NRF2 pathway—TGFB1—periodontitis	0.00289	0.00289	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—CCR2—periodontitis	0.00285	0.00285	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—PPARA—periodontitis	0.00285	0.00285	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—ADRB1—periodontitis	0.00284	0.00284	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CXCL3—periodontitis	0.00279	0.00279	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CXCL3—periodontitis	0.00278	0.00278	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CXCL3—periodontitis	0.00273	0.00273	CbGpPWpGaD
Escitalopram—CYP2D6—Biological oxidations—GGT1—periodontitis	0.00269	0.00269	CbGpPWpGaD
Escitalopram—CHRM1—Regulation of Actin Cytoskeleton—FGF2—periodontitis	0.00261	0.00261	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—TNF—periodontitis	0.00256	0.00256	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CXCL3—periodontitis	0.00253	0.00253	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CXCL3—periodontitis	0.00252	0.00252	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—NOS2—periodontitis	0.00252	0.00252	CbGpPWpGaD
Escitalopram—SLC6A2—NRF2 pathway—TGFB1—periodontitis	0.00248	0.00248	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CXCL3—periodontitis	0.00248	0.00248	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—CCR2—periodontitis	0.00247	0.00247	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—CCR2—periodontitis	0.00246	0.00246	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—ADRB1—periodontitis	0.00246	0.00246	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—ADRB1—periodontitis	0.00245	0.00245	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—CCR2—periodontitis	0.00242	0.00242	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—ADRB1—periodontitis	0.00241	0.00241	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—VIP—periodontitis	0.00232	0.00232	CbGpPWpGaD
Escitalopram—SLC6A3—NRF2 pathway—TGFB1—periodontitis	0.0022	0.0022	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—VIP—periodontitis	0.00211	0.00211	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CXCR2—periodontitis	0.00207	0.00207	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—IL6—periodontitis	0.00206	0.00206	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—VIP—periodontitis	0.00201	0.00201	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—VIP—periodontitis	0.00201	0.00201	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—VIP—periodontitis	0.00198	0.00198	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CXCR2—periodontitis	0.00188	0.00188	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00184	0.00184	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—VIP—periodontitis	0.00183	0.00183	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—VIP—periodontitis	0.00182	0.00182	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CXCR2—periodontitis	0.00179	0.00179	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—VIP—periodontitis	0.00179	0.00179	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CXCR2—periodontitis	0.00179	0.00179	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CXCR2—periodontitis	0.00176	0.00176	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—GGT1—periodontitis	0.00176	0.00176	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CXCL3—periodontitis	0.00172	0.00172	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—PPARA—periodontitis	0.00169	0.00169	CbGpPWpGaD
Escitalopram—SLC6A4—Circadian rythm related genes—IL6—periodontitis	0.00168	0.00168	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CXCR2—periodontitis	0.00163	0.00163	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CXCR2—periodontitis	0.00162	0.00162	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CCR2—periodontitis	0.00161	0.00161	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—ADRB1—periodontitis	0.0016	0.0016	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CXCR2—periodontitis	0.0016	0.0016	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.0016	0.0016	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00159	0.00159	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—periodontitis	0.00157	0.00157	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SLC52A3—periodontitis	0.00152	0.00152	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—PPARA—periodontitis	0.0015	0.0015	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCL3—periodontitis	0.00149	0.00149	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCL3—periodontitis	0.00149	0.00149	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCL3—periodontitis	0.00147	0.00147	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CCR2—periodontitis	0.00146	0.00146	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00146	0.00146	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—ADRB1—periodontitis	0.00146	0.00146	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—CCL2—periodontitis	0.0014	0.0014	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SLC52A3—periodontitis	0.0014	0.0014	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CCR2—periodontitis	0.0014	0.0014	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CCR2—periodontitis	0.00139	0.00139	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—ADRB1—periodontitis	0.00139	0.00139	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—ADRB1—periodontitis	0.00139	0.00139	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CCR2—periodontitis	0.00137	0.00137	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—ADRB1—periodontitis	0.00136	0.00136	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCR2—periodontitis	0.00127	0.00127	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00126	0.00126	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCR2—periodontitis	0.00126	0.00126	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—ADRB1—periodontitis	0.00126	0.00126	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00126	0.00126	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—ADRB1—periodontitis	0.00126	0.00126	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VIP—periodontitis	0.00125	0.00125	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCR2—periodontitis	0.00124	0.00124	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—periodontitis	0.00124	0.00124	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—ADRB1—periodontitis	0.00124	0.00124	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—CCL2—periodontitis	0.00122	0.00122	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—CCL2—periodontitis	0.00121	0.00121	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—CCL2—periodontitis	0.00119	0.00119	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—periodontitis	0.00112	0.00112	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CXCR2—periodontitis	0.00111	0.00111	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—CXCL8—periodontitis	0.00111	0.00111	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—MMP3—periodontitis	0.00111	0.00111	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.00111	0.00111	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VIP—periodontitis	0.00108	0.00108	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VIP—periodontitis	0.00108	0.00108	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VIP—periodontitis	0.00106	0.00106	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—IL6—periodontitis	0.00101	0.00101	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCR2—periodontitis	0.000963	0.000963	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—CXCL8—periodontitis	0.000962	0.000962	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—MMP3—periodontitis	0.000961	0.000961	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCR2—periodontitis	0.00096	0.00096	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—CXCL8—periodontitis	0.000959	0.000959	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000959	0.000959	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—MMP3—periodontitis	0.000958	0.000958	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000955	0.000955	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCR2—periodontitis	0.000945	0.000945	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—CXCL8—periodontitis	0.000944	0.000944	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—MMP3—periodontitis	0.000943	0.000943	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—periodontitis	0.000941	0.000941	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC52A3—periodontitis	0.000916	0.000916	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ACP5—periodontitis	0.000898	0.000898	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCR2—periodontitis	0.000864	0.000864	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ADRB1—periodontitis	0.00086	0.00086	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ACP5—periodontitis	0.000826	0.000826	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—periodontitis	0.000802	0.000802	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCR2—periodontitis	0.000749	0.000749	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCR2—periodontitis	0.000746	0.000746	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ADRB1—periodontitis	0.000745	0.000745	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ADRB1—periodontitis	0.000743	0.000743	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCR2—periodontitis	0.000735	0.000735	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ADRB1—periodontitis	0.000732	0.000732	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CCL2—periodontitis	0.000721	0.000721	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NTRK1—periodontitis	0.000704	0.000704	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MMP3—periodontitis	0.000655	0.000655	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CXCL8—periodontitis	0.000628	0.000628	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CCL2—periodontitis	0.000625	0.000625	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CCL2—periodontitis	0.000623	0.000623	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CCL2—periodontitis	0.000613	0.000613	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NTRK1—periodontitis	0.00061	0.00061	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NTRK1—periodontitis	0.000608	0.000608	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NTRK1—periodontitis	0.000599	0.000599	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CXCL8—periodontitis	0.00057	0.00057	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP3—periodontitis	0.000567	0.000567	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP3—periodontitis	0.000566	0.000566	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP3—periodontitis	0.000557	0.000557	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CXCL8—periodontitis	0.000544	0.000544	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CXCL8—periodontitis	0.000542	0.000542	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ACP5—periodontitis	0.00054	0.00054	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CXCL8—periodontitis	0.000534	0.000534	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—periodontitis	0.000522	0.000522	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GGT1—periodontitis	0.000499	0.000499	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CXCL8—periodontitis	0.000494	0.000494	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CXCL8—periodontitis	0.000492	0.000492	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CXCL8—periodontitis	0.000485	0.000485	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GGT1—periodontitis	0.000459	0.000459	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCL2—periodontitis	0.000426	0.000426	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—FGF2—periodontitis	0.000385	0.000385	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCL2—periodontitis	0.000369	0.000369	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCL2—periodontitis	0.000368	0.000368	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCL2—periodontitis	0.000362	0.000362	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARA—periodontitis	0.000357	0.000357	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CXCL8—periodontitis	0.000337	0.000337	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FGF2—periodontitis	0.000333	0.000333	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FGF2—periodontitis	0.000332	0.000332	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARA—periodontitis	0.000329	0.000329	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FGF2—periodontitis	0.000327	0.000327	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—periodontitis	0.00032	0.00032	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MMP9—periodontitis	0.000304	0.000304	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GGT1—periodontitis	0.0003	0.0003	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCL8—periodontitis	0.000292	0.000292	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCL8—periodontitis	0.000291	0.000291	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCL8—periodontitis	0.000286	0.000286	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—periodontitis	0.000277	0.000277	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—periodontitis	0.000276	0.000276	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—periodontitis	0.000272	0.000272	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP9—periodontitis	0.000264	0.000264	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP9—periodontitis	0.000263	0.000263	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP9—periodontitis	0.000259	0.000259	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TGFB1—periodontitis	0.000251	0.000251	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS2—periodontitis	0.000232	0.000232	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TGFB1—periodontitis	0.000217	0.000217	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TGFB1—periodontitis	0.000217	0.000217	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARA—periodontitis	0.000215	0.000215	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS2—periodontitis	0.000214	0.000214	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TGFB1—periodontitis	0.000213	0.000213	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—periodontitis	0.000189	0.000189	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—periodontitis	0.000164	0.000164	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—periodontitis	0.000163	0.000163	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—periodontitis	0.000161	0.000161	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS2—periodontitis	0.00014	0.00014	CbGpPWpGaD
